Clinical trial
Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective…
NCT00044876 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00044876 |
|---|---|
| Title | Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist |
| Official title | Treatment of Leiomyomata With the Selective Progesterone Receptor Modulator CDB-2914 |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leiomyoma |
| Intervention type | Drug |
| Interventions | CDB-2914 |
| Enrollment | 56 |
| Start date | Sep 2, 2002 |
| Primary completion | Jun 16, 2007 |
| Completion | Oct 1, 2015 |
| First posted | Sep 6, 2002 |
| Last update posted | Dec 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: